Lido Advisors, LLC Novartis Ag Transaction History

Lido Advisors, LLC

  • $25.9 Billion
  • Q2 2025

A detailed history of Lido Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Lido Advisors, LLC holds 30,001 shares of NVS stock, worth $3.71 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,001
Previous 16,120 86.11%
Holding current value
$3.71 Million
Previous $1.8 Million 102.0%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$101.96 - $121.01 $1.42 Million - $1.68 Million
13,881 Added 86.11%
30,001 $3.63 Million
Q1 2025

May 15, 2025
SELL
$97.14 - $115.57 $5,634 - $6,703
-58 Reduced 0.36%
16,120 $1.8 Million
Q4 2024

Feb 14, 2025
BUY
$96.78 - $117.18 $104,619 - $126,671
1,081 Added 7.16%
16,178 $1.57 Million
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $102,839 - $117,142
969 Added 6.86%
15,097 $1.74 Million
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $37,028 - $42,948
-400 Reduced 2.75%
14,128 $1.5 Million
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $149,764 - $170,514
1,572 Added 12.13%
14,528 $1.41 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $78,798 - $86,715
854 Added 7.06%
12,956 $1.31 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $30,597 - $33,956
323 Added 2.74%
12,102 $1.23 Million
Q2 2023

Aug 09, 2023
BUY
$92.52 - $104.91 $413,471 - $468,842
4,469 Added 61.14%
11,779 $1.19 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $229,205 - $265,807
2,864 Added 64.42%
7,310 $672,000
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $138,709 - $169,866
-1,836 Reduced 29.23%
4,446 $403,000
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $69,984 - $81,849
938 Added 17.55%
6,282 $477,000
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $17,633 - $20,531
-219 Reduced 3.94%
5,344 $451,000
Q1 2022

May 17, 2022
SELL
$80.11 - $90.62 $20,027 - $22,655
-250 Reduced 4.3%
5,563 $488,000
Q4 2021

Feb 15, 2022
SELL
$79.7 - $88.13 $80,417 - $88,923
-1,009 Reduced 14.79%
5,813 $508,000
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $18,891 - $21,977
231 Added 3.5%
6,822 $558,000
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $75,011 - $82,852
-880 Reduced 11.78%
6,591 $601,000
Q1 2021

May 13, 2021
BUY
$83.5 - $98.47 $200,483 - $236,426
2,401 Added 47.36%
7,471 $639,000
Q4 2020

Feb 08, 2021
SELL
$78.07 - $94.43 $15,926 - $19,263
-204 Reduced 3.87%
5,070 $478,000
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $2,217 - $2,457
-27 Reduced 0.51%
5,274 $459,000
Q2 2020

Aug 12, 2020
BUY
$80.93 - $91.1 $86,756 - $97,659
1,072 Added 25.35%
5,301 $463,000
Q1 2020

May 13, 2020
BUY
$70.67 - $99.01 $6,430 - $9,009
91 Added 2.2%
4,229 $349,000
Q4 2019

Feb 07, 2020
BUY
$84.35 - $95.37 $65,371 - $73,911
775 Added 23.04%
4,138 $392,000
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $15,482 - $17,061
-181 Reduced 5.11%
3,363 $292,000
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $26,013 - $32,016
345 Added 10.78%
3,544 $323,000
Q1 2019

May 10, 2019
SELL
$75.32 - $86.15 $16,043 - $18,349
-213 Reduced 6.24%
3,199 $307,000
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $3,020 - $3,362
41 Added 1.22%
3,412 $292,000
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $4,886 - $5,652
-73 Reduced 2.12%
3,371 $290,000
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $17,071 - $19,293
263 Added 8.27%
3,444 $260,000
Q1 2018

May 10, 2018
SELL
$70.39 - $84.15 $1,759 - $2,103
-25 Reduced 0.78%
3,181 $257,000
Q4 2017

Feb 15, 2018
BUY
$72.33 - $77.64 $231,889 - $248,913
3,206
3,206 $269,000

Others Institutions Holding NVS

# of Institutions
1,582
Shares Held
136M
Call Options Held
1.72M
Put Options Held
1.7M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $266B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email